Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype ; volume:8 ; number:1 ; day:5 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (5.2.2018), 1-9, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Wiley, Christopher D.
- Beteiligte Personen und Organisationen
-
Schaum, Nicholas
Alimirah, Fatouma
Lopez-Dominguez, Jose Alberto
Orjalo, Arturo V.
Scott, Gary
Desprez, Pierre-Yves
Benz, Christopher
Davalos, Albert R.
Campisi, Judith
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-20000-4
- URN
-
urn:nbn:de:1111-201803272801
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wiley, Christopher D.
- Schaum, Nicholas
- Alimirah, Fatouma
- Lopez-Dominguez, Jose Alberto
- Orjalo, Arturo V.
- Scott, Gary
- Desprez, Pierre-Yves
- Benz, Christopher
- Davalos, Albert R.
- Campisi, Judith
- SpringerLink (Online service)
Ähnliche Objekte (12)
Small-Molecule Inhibitors of p53-MDM2 interactions
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation
Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition
Small-Molecule Inhibitors of p53-MDM2 interactions
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation
Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition
Small-Molecule Inhibitors of p53-MDM2 interactions
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation
Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity